Page last updated: 2024-11-04

sulfasalazine and Dysentery

sulfasalazine has been researched along with Dysentery in 1 studies

Sulfasalazine: A drug that is used in the management of inflammatory bowel diseases. Its activity is generally considered to lie in its metabolic breakdown product, 5-aminosalicylic acid (see MESALAMINE) released in the colon. (From Martindale, The Extra Pharmacopoeia, 30th ed, p907)
sulfasalazine : An azobenzene consisting of diphenyldiazene having a carboxy substituent at the 4-position, a hydroxy substituent at the 3-position and a 2-pyridylaminosulphonyl substituent at the 4'-position.

Dysentery: Acute inflammation of the intestine associated with infectious DIARRHEA of various etiologies, generally acquired by eating contaminated food containing TOXINS, BIOLOGICAL derived from BACTERIA or other microorganisms. Dysentery is characterized initially by watery FECES then by bloody mucoid stools. It is often associated with ABDOMINAL PAIN; FEVER; and DEHYDRATION.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Naudin, G1
Lagadec, B1
Bernard, A1
Conte-Marti, J1
Roucou, Y1

Other Studies

1 other study available for sulfasalazine and Dysentery

ArticleYear
[Fulminating ulcero-hemorrhagic rectocolitis with toxic megacolon. Treatment by emergency colectomy].
    La semaine des hopitaux : organe fonde par l'Association d'enseignement medical des hopitaux de Paris, 1973, Oct-14, Volume: 49, Issue:41

    Topics: Adult; Aminocaproates; Betamethasone; Cephalothin; Colectomy; Colitis, Ulcerative; Dysentery; Gentam

1973